| Target Price | $286.62 |
| Price | $272.36 |
| Potential | 5.23% |
| Number of Estimates | 48 |
| 48 Analysts have issued a price target Apple 2026 . The average Apple target price is $286.62. This is 5.23% higher than the current stock price. The highest price target is $341.25 25.29% , the lowest is $217.15 20.27% . | |
| A rating was issued by 56 analysts: 38 Analysts recommend Apple to buy, 16 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Apple stock has an average upside potential 2026 of 5.23% . Most analysts recommend the Apple stock at Purchase. |
48 Analysts have issued a sales forecast Apple 2026 . The average Apple sales estimate is $462b . This is 10.94% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $490b 17.69% , the lowest is $429b 2.97% .
This results in the following potential growth metrics:
| 2025 | $416b | 6.43% |
|---|---|---|
| 2026 | $462b | 10.94% |
| 2027 | $493b | 6.71% |
| 2028 | $525b | 6.47% |
| 2029 | $558b | 6.35% |
| 2030 | $589b | 5.50% |
| 2031 | $617b | 4.83% |
34 Analysts have issued an Apple EBITDA forecast 2026. The average Apple EBITDA estimate is $160b . This is 10.82% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $173b 19.84% , the lowest is $145b 0.11% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2025 | $145b | 7.49% |
|---|---|---|
| 2026 | $160b | 10.82% |
| 2027 | $173b | 8.11% |
| 2028 | $187b | 7.65% |
| 2029 | $204b | 9.27% |
| 2030 | $223b | 9.21% |
| 2031 | $238b | 6.87% |
| 2025 | 34.78% | 1.00% |
|---|---|---|
| 2026 | 34.74% | 0.12% |
| 2027 | 35.20% | 1.32% |
| 2028 | 35.59% | 1.11% |
| 2029 | 36.57% | 2.75% |
| 2030 | 37.85% | 3.50% |
| 2031 | 38.59% | 1.96% |
49 Apple Analysts have issued a net profit forecast 2026. The average Apple net profit estimate is $125b . This is 11.25% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $140b 24.78% , the lowest is $112b 0.30% .
This results in the following potential growth metrics and future Net Margins:
| 2025 | $112b | 19.50% |
|---|---|---|
| 2026 | $125b | 11.25% |
| 2027 | $138b | 10.43% |
| 2028 | $151b | 10.04% |
| 2029 | $181b | 19.82% |
| 2030 | $207b | 14.37% |
| 2031 | $250b | 20.26% |
| 2025 | 26.92% | 12.28% |
|---|---|---|
| 2026 | 26.99% | 0.28% |
| 2027 | 27.93% | 3.48% |
| 2028 | 28.87% | 3.37% |
| 2029 | 32.52% | 12.64% |
| 2030 | 35.26% | 8.43% |
| 2031 | 40.45% | 14.72% |
49 Analysts have issued a Apple forecast for earnings per share. The average Apple EPS is $8.43 . This is 11.95% higher than earnings per share in the financial year 2025. The highest EPS forecast is $9.46 25.63% , the lowest is $7.60 0.93% .
This results in the following potential growth metrics and future valuations:
| 2025 | $7.47 | 22.86% |
|---|---|---|
| 2026 | $8.43 | 12.85% |
| 2027 | $9.31 | 10.44% |
| 2028 | $10.25 | 10.10% |
| 2029 | $12.28 | 19.80% |
| 2030 | $14.05 | 14.41% |
| 2031 | $16.89 | 20.21% |
| Current | 36.17 | 12.73% |
|---|---|---|
| 2026 | 32.29 | 10.73% |
| 2027 | 29.24 | 9.45% |
| 2028 | 26.57 | 9.13% |
| 2029 | 22.18 | 16.52% |
| 2030 | 19.39 | 12.58% |
| 2031 | 16.12 | 16.86% |
Based on analysts' sales estimates for 2026, the Apple stock is valued at an EV/Sales of 8.81 and an P/S ratio of 8.72 .
This results in the following potential growth metrics and future valuations:
| Current | 9.78 | 1.61% |
|---|---|---|
| 2026 | 8.81 | 9.90% |
| 2027 | 8.26 | 6.29% |
| 2028 | 7.76 | 6.07% |
| 2029 | 7.29 | 5.97% |
| 2030 | 6.91 | 5.21% |
| 2031 | 6.59 | 4.61% |
| Current | 9.67 | 1.70% |
|---|---|---|
| 2026 | 8.72 | 9.86% |
| 2027 | 8.17 | 6.29% |
| 2028 | 7.67 | 6.07% |
| 2029 | 7.21 | 5.97% |
| 2030 | 6.84 | 5.21% |
| 2031 | 6.52 | 4.60% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Dec 17 2025 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Dec 09 2025 |
| Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Dec 08 2025 |
| Wedbush |
Outperform
➜
Outperform
|
Unchanged | Dec 08 2025 |
| CLSA |
Outperform
➜
Outperform
|
Unchanged | Dec 05 2025 |
| Loop Capital |
Buy
➜
Buy
|
Unchanged | Dec 02 2025 |
| Rosenblatt |
Neutral
➜
Neutral
|
Unchanged | Nov 04 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Dec 17 2025 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Dec 09 2025 |
|
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Dec 08 2025 |
|
Unchanged
Wedbush:
Outperform
➜
Outperform
|
Dec 08 2025 |
|
Unchanged
CLSA:
Outperform
➜
Outperform
|
Dec 05 2025 |
|
Unchanged
Loop Capital:
Buy
➜
Buy
|
Dec 02 2025 |
|
Unchanged
Rosenblatt:
Neutral
➜
Neutral
|
Nov 04 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


